Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bayer
Biotech
Oryon shines out of stealth with $21M to fight Parkinson's
Oryon Cell Therapies is launching with a $21 million series A round and announcing that physician entrepreneur Ron Cohen, M.D., will be its CEO.
Will Maddox
Mar 23, 2026 5:00am
Bayer ditches 1 AAV gene therapy from Pompe disease pair
Mar 4, 2026 9:59am
Racing BMS and J&J, Bayer ties asundexian to 26% stroke decrease
Feb 5, 2026 12:15pm
Bayer strikes deal with Attralus for 2 diagnostic tracers
Jan 12, 2026 10:00am
Bayer's asundexian cuts stroke risk in phase 3
Nov 24, 2025 6:25am
Bayer opens Beijing incubator, names initial occupants
Nov 17, 2025 10:18am
